Compile Data Set for Download or QSAR

Found 445 hits with Last Name = 'malagu' and Initial = 'kf'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174595 (US9102670, 14a) Show SMILES COc1ccc(cc1C(O)=O)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H29N5O5/c1-15-13-34-10-8-29(15)23-18-5-6-20(17-4-7-21(33-3)19(12-17)24(31)32)26-22(18)27-25(28-23)30-9-11-35-14-16(30)2/h4-7,12,15-16H,8-11,13-14H2,1-3H3,(H,31,32)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.150	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174368 (US9102670, 1cg) Show SMILES C[C@H]1CN(C[C@@H](C)O1)c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(O)cc1 |r| Show InChI InChI=1S/C24H29N5O3/c1-15-14-31-11-10-29(15)23-20-8-9-21(18-4-6-19(30)7-5-18)25-22(20)26-24(27-23)28-12-16(2)32-17(3)13-28/h4-9,15-17,30H,10-14H2,1-3H3/t15-,16-,17+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.260	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174414 (US9102670, 1du) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(CNS(C)(=O)=O)cc1 |r| Show InChI InChI=1S/C25H32N6O4S/c1-17-15-34-12-10-30(17)24-21-8-9-22(20-6-4-19(5-7-20)14-26-36(3,32)33)27-23(21)28-25(29-24)31-11-13-35-16-18(31)2/h4-9,17-18,26H,10-16H2,1-3H3/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.390	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174467 (US9102670, 4a) Show SMILES CNCc1ccc(cc1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H32N6O2/c1-17-15-32-12-10-30(17)24-21-8-9-22(20-6-4-19(5-7-20)14-26-3)27-23(21)28-25(29-24)31-11-13-33-16-18(31)2/h4-9,17-18,26H,10-16H2,1-3H3/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.60	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174288 (US9102670, 1c) Show SMILES CCC1CCCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(OC)c(CO)c1 |r| Show InChI InChI=1S/C27H35N5O3/c1-4-21-7-5-6-12-32(21)27-29-25-22(26(30-27)31-13-14-35-17-18(31)2)9-10-23(28-25)19-8-11-24(34-3)20(15-19)16-33/h8-11,15,18,21,33H,4-7,12-14,16-17H2,1-3H3/t18-,21?/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.84	n/a	n/a	n/a	n/a	n/a	n/a
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174287 (US9102670, 1b) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C26H33N5O4/c1-16-15-34-10-9-31(16)25-21-6-7-22(19-5-8-23(33-4)20(11-19)14-32)27-24(21)28-26(29-25)30-12-17(2)35-18(3)13-30/h5-8,11,16-18,32H,9-10,12-15H2,1-4H3/t16-,17-,18+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.85	n/a	n/a	n/a	n/a	n/a	n/a
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174471 (US9102670, 4e) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(CNC2CCOCC2)cc1 |r| Show InChI InChI=1S/C29H38N6O3/c1-20-18-37-15-11-34(20)28-25-7-8-26(31-27(25)32-29(33-28)35-12-16-38-19-21(35)2)23-5-3-22(4-6-23)17-30-24-9-13-36-14-10-24/h3-8,20-21,24,30H,9-19H2,1-2H3/t20-,21-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.90	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174472 (US9102670, 4f) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(CNCCO)cc1 |r| Show InChI InChI=1S/C26H34N6O3/c1-18-16-34-13-10-31(18)25-22-7-8-23(21-5-3-20(4-6-21)15-27-9-12-33)28-24(22)29-26(30-25)32-11-14-35-17-19(32)2/h3-8,18-19,27,33H,9-17H2,1-2H3/t18-,19-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.97	n/a	n/a	n/a	n/a	n/a	n/a
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174293 (US9102670, 1h) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(O)c1 |r| Show InChI InChI=1S/C23H27N5O3/c1-15-13-30-10-8-27(15)22-19-6-7-20(17-4-3-5-18(29)12-17)24-21(19)25-23(26-22)28-9-11-31-14-16(28)2/h3-7,12,15-16,29H,8-11,13-14H2,1-2H3/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174289 (US9102670, 1d) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccccc1 |r| Show InChI InChI=1S/C23H27N5O2/c1-16-14-29-12-10-27(16)22-19-8-9-20(18-6-4-3-5-7-18)24-21(19)25-23(26-22)28-11-13-30-15-17(28)2/h3-9,16-17H,10-15H2,1-2H3/t16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.45	n/a	n/a	n/a	n/a	n/a	n/a
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174686 (US9102670, 18ca) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCNCC1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H30N6O3/c1-16-15-33-12-11-30(16)23-19-4-5-20(17-3-6-21(32-2)18(13-17)14-31)26-22(19)27-24(28-23)29-9-7-25-8-10-29/h3-6,13,16,25,31H,7-12,14-15H2,1-2H3/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.60	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174413 (US9102670, 1dt) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc2CNC(=O)c2c1 |r| Show InChI InChI=1S/C25H28N6O3/c1-15-13-33-9-7-30(15)23-19-5-6-21(17-3-4-18-12-26-24(32)20(18)11-17)27-22(19)28-25(29-23)31-8-10-34-14-16(31)2/h3-6,11,15-16H,7-10,12-14H2,1-2H3,(H,26,32)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.60	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174347 (US9102670, 1bl) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(cc1)C#N |r| Show InChI InChI=1S/C24H26N6O2/c1-16-14-31-11-9-29(16)23-20-7-8-21(19-5-3-18(13-25)4-6-19)26-22(20)27-24(28-23)30-10-12-32-15-17(30)2/h3-8,16-17H,9-12,14-15H2,1-2H3/t16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174472 (US9102670, 4f) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(CNCCO)cc1 |r| Show InChI InChI=1S/C26H34N6O3/c1-18-16-34-13-10-31(18)25-22-7-8-23(21-5-3-20(4-6-21)15-27-9-12-33)28-24(22)29-26(30-25)32-11-14-35-17-19(32)2/h3-8,18-19,27,33H,9-17H2,1-2H3/t18-,19-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<2.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174712 (US9102670, 18db) Show SMILES CNCCOc1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(OC)c(CO)c1 |r| Show InChI InChI=1S/C23H29N5O4/c1-15-14-31-11-9-28(15)22-18-5-6-19(16-4-7-20(30-3)17(12-16)13-29)25-21(18)26-23(27-22)32-10-8-24-2/h4-7,12,15,24,29H,8-11,13-14H2,1-3H3/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM50429706 (CHEMBL2336320 | US9102670, 14b) Show SMILES COc1ccc(cc1C(N)=O)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H30N6O4/c1-15-13-34-10-8-30(15)24-18-5-6-20(17-4-7-21(33-3)19(12-17)22(26)32)27-23(18)28-25(29-24)31-9-11-35-14-16(31)2/h4-7,12,15-16H,8-11,13-14H2,1-3H3,(H2,26,32)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.20	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174418 (US9102670, 1dy) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc2CC(=O)Nc2c1 |r| Show InChI InChI=1S/C25H28N6O3/c1-15-13-33-9-7-30(15)24-19-5-6-20(17-3-4-18-12-22(32)26-21(18)11-17)27-23(19)28-25(29-24)31-8-10-34-14-16(31)2/h3-6,11,15-16H,7-10,12-14H2,1-2H3,(H,26,32)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174514 (US9102670, 4av) Show SMILES CCN(CC)CCCNCc1cc(ccc1OC)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C32H47N7O3/c1-6-37(7-2)14-8-13-33-20-26-19-25(9-12-29(26)40-5)28-11-10-27-30(34-28)35-32(39-16-18-42-22-24(39)4)36-31(27)38-15-17-41-21-23(38)3/h9-12,19,23-24,33H,6-8,13-18,20-22H2,1-5H3/t23-,24-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.80	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174602 (US9102670, 15a) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(NS(=O)(=O)CCO)c1 |r| Show InChI InChI=1S/C25H32N6O5S/c1-17-15-35-11-8-30(17)24-21-6-7-22(19-4-3-5-20(14-19)29-37(33,34)13-10-32)26-23(21)27-25(28-24)31-9-12-36-16-18(31)2/h3-7,14,17-18,29,32H,8-13,15-16H2,1-2H3/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.30	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174290 (US9102670, 1e) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(O)cc1 |r| Show InChI InChI=1S/C23H27N5O3/c1-15-13-30-11-9-27(15)22-19-7-8-20(17-3-5-18(29)6-4-17)24-21(19)25-23(26-22)28-10-12-31-14-16(28)2/h3-8,15-16,29H,9-14H2,1-2H3/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.40	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174360 (US9102670, 1by) Show SMILES C[C@H]1CN(C[C@@H](C)O1)c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(CO)cc1 |r| Show InChI InChI=1S/C25H31N5O3/c1-16-15-32-11-10-30(16)24-21-8-9-22(20-6-4-19(14-31)5-7-20)26-23(21)27-25(28-24)29-12-17(2)33-18(3)13-29/h4-9,16-18,31H,10-15H2,1-3H3/t16-,17-,18+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.60	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174703 (US9102670, 18cs) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N(CCO)C(C)C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H33N5O4/c1-16(2)29(9-11-31)25-27-23-20(24(28-25)30-10-12-34-15-17(30)3)6-7-21(26-23)18-5-8-22(33-4)19(13-18)14-32/h5-8,13,16-17,31-32H,9-12,14-15H2,1-4H3/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174439 (US9102670, 3e) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(c1)C(=O)NCCF |r| Show InChI InChI=1S/C26H31FN6O3/c1-17-15-35-12-10-32(17)24-21-6-7-22(19-4-3-5-20(14-19)25(34)28-9-8-27)29-23(21)30-26(31-24)33-11-13-36-16-18(33)2/h3-7,14,17-18H,8-13,15-16H2,1-2H3,(H,28,34)/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174424 (US9102670, 1ee) Show SMILES C[C@H]1COCCN1c1nc(nc2nc(ccc12)-c1cccc(NS(C)(=O)=O)c1)N1CCOCC1 |r| Show InChI InChI=1S/C23H28N6O4S/c1-16-15-33-13-10-29(16)22-19-6-7-20(17-4-3-5-18(14-17)27-34(2,30)31)24-21(19)25-23(26-22)28-8-11-32-12-9-28/h3-7,14,16,27H,8-13,15H2,1-2H3/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.80	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174767 (US9102670, 1de) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc2c(NCCNC2=O)c1 Show InChI InChI=1S/C26H31N7O3/c1-16-14-35-11-9-32(16)24-20-5-6-21(18-3-4-19-22(13-18)27-7-8-28-25(19)34)29-23(20)30-26(31-24)33-10-12-36-15-17(33)2/h3-6,13,16-17,27H,7-12,14-15H2,1-2H3,(H,28,34)/t16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.90	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174291 (US9102670, 1f) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(C)cc1 |r| Show InChI InChI=1S/C24H29N5O2/c1-16-4-6-19(7-5-16)21-9-8-20-22(25-21)26-24(29-11-13-31-15-18(29)3)27-23(20)28-10-12-30-14-17(28)2/h4-9,17-18H,10-15H2,1-3H3/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174357 (US9102670, 1bv) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccoc1 |r| Show InChI InChI=1S/C21H25N5O3/c1-14-11-28-9-6-25(14)20-17-3-4-18(16-5-8-27-13-16)22-19(17)23-21(24-20)26-7-10-29-12-15(26)2/h3-5,8,13-15H,6-7,9-12H2,1-2H3/t14-,15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174441 (US9102670, 3g) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(c1)C(=O)N1CC[C@@H](O)C1 |r| Show InChI InChI=1S/C28H34N6O4/c1-18-16-37-12-10-33(18)26-23-6-7-24(29-25(23)30-28(31-26)34-11-13-38-17-19(34)2)20-4-3-5-21(14-20)27(36)32-9-8-22(35)15-32/h3-7,14,18-19,22,35H,8-13,15-17H2,1-2H3/t18-,19-,22+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.20	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174699 (US9102670, 18co) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCNC(=O)C1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H30N6O4/c1-15-14-35-11-10-30(15)23-19-5-6-20(17-4-7-21(34-3)18(12-17)13-32)27-22(19)28-25(29-23)31-9-8-26-24(33)16(31)2/h4-7,12,15-16,32H,8-11,13-14H2,1-3H3,(H,26,33)/t15-,16?/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.20	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM60569 (US9102670, 1dn) Show SMILES COc1ccc(cc1C(N)=O)-c1ccc2c(nc(nc2n1)N1CCSCC1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H28N6O3S/c1-15-14-33-10-7-30(15)23-17-4-5-19(16-3-6-20(32-2)18(13-16)21(25)31)26-22(17)27-24(28-23)29-8-11-34-12-9-29/h3-6,13,15H,7-12,14H2,1-2H3,(H2,25,31)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174294 (US9102670, 1i) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(CO)c1 |r| Show InChI InChI=1S/C24H29N5O3/c1-16-14-31-10-8-28(16)23-20-6-7-21(19-5-3-4-18(12-19)13-30)25-22(20)26-24(27-23)29-9-11-32-15-17(29)2/h3-7,12,16-17,30H,8-11,13-15H2,1-2H3/t16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.60	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174296 (US9102670, 1l) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOCC1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H29N5O4/c1-16-15-33-12-9-29(16)23-19-4-5-20(17-3-6-21(31-2)18(13-17)14-30)25-22(19)26-24(27-23)28-7-10-32-11-8-28/h3-6,13,16,30H,7-12,14-15H2,1-2H3/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174700 (US9102670, 18cp) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(N[C@H](C)C(N)=O)nc2n1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C23H28N6O4/c1-13-12-33-9-8-29(13)22-17-5-6-18(15-4-7-19(32-3)16(10-15)11-30)26-21(17)27-23(28-22)25-14(2)20(24)31/h4-7,10,13-14,30H,8-9,11-12H2,1-3H3,(H2,24,31)(H,25,26,27,28)/t13-,14+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174327 (US9102670, 1ar) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccncc1 |r| Show InChI InChI=1S/C22H26N6O2/c1-15-13-29-11-9-27(15)21-18-3-4-19(17-5-7-23-8-6-17)24-20(18)25-22(26-21)28-10-12-30-14-16(28)2/h3-8,15-16H,9-14H2,1-2H3/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174702 (US9102670, 18cr) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N(C)CCO)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C23H29N5O4/c1-15-14-32-11-9-28(15)22-18-5-6-19(16-4-7-20(31-3)17(12-16)13-30)24-21(18)25-23(26-22)27(2)8-10-29/h4-7,12,15,29-30H,8-11,13-14H2,1-3H3/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.30	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174364 (US9102670, 1cc) Show SMILES COc1ccc(cc1F)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H30FN5O3/c1-15-14-33-10-9-31(15)24-19-6-7-21(18-5-8-22(32-4)20(26)11-18)27-23(19)28-25(29-24)30-12-16(2)34-17(3)13-30/h5-8,11,15-17H,9-10,12-14H2,1-4H3/t15-,16-,17+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.40	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM60571 (US9102670, 1dp) Show SMILES COc1ccc(cc1C(N)=O)-c1ccc2c(nc(nc2n1)N1CCOCC1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H28N6O4/c1-15-14-34-12-9-30(15)23-17-4-5-19(16-3-6-20(32-2)18(13-16)21(25)31)26-22(17)27-24(28-23)29-7-10-33-11-8-29/h3-6,13,15H,7-12,14H2,1-2H3,(H2,25,31)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM60572 (US9102670, 1az) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(N)cc1 |r| Show InChI InChI=1S/C23H28N6O2/c1-15-13-30-11-9-28(15)22-19-7-8-20(17-3-5-18(24)6-4-17)25-21(19)26-23(27-22)29-10-12-31-14-16(29)2/h3-8,15-16H,9-14,24H2,1-2H3/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.87	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174314 (US9102670, 1ad) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(F)c(c1)C(O)=O |r| Show InChI InChI=1S/C24H26FN5O4/c1-14-12-33-9-7-29(14)22-17-4-6-20(16-3-5-19(25)18(11-16)23(31)32)26-21(17)27-24(28-22)30-8-10-34-13-15(30)2/h3-6,11,14-15H,7-10,12-13H2,1-2H3,(H,31,32)/t14-,15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6.90	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174480 (US9102670, 4n) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(CNCC2CC2)c1 |r| Show InChI InChI=1S/C28H36N6O2/c1-19-17-35-12-10-33(19)27-24-8-9-25(23-5-3-4-22(14-23)16-29-15-21-6-7-21)30-26(24)31-28(32-27)34-11-13-36-18-20(34)2/h3-5,8-9,14,19-21,29H,6-7,10-13,15-18H2,1-2H3/t19-,20-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174399 (US9102670, 1dm) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccnc(NC(C)=O)c1 |r| Show InChI InChI=1S/C24H29N7O3/c1-15-13-33-10-8-30(15)23-19-4-5-20(18-6-7-25-21(12-18)26-17(3)32)27-22(19)28-24(29-23)31-9-11-34-14-16(31)2/h4-7,12,15-16H,8-11,13-14H2,1-3H3,(H,25,26,32)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174325 (US9102670, 1ao) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1ccc(cc1)C(N)=O |r| Show InChI InChI=1S/C24H28N6O3/c1-15-13-32-11-9-29(15)23-19-7-8-20(17-3-5-18(6-4-17)21(25)31)26-22(19)27-24(28-23)30-10-12-33-14-16(30)2/h3-8,15-16H,9-14H2,1-2H3,(H2,25,31)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8.30	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174733 (US9102670, 19g) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)-c1cc(cc(c1)[N+]([O-])=O)C(O)=O)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C27H25N5O7/c1-15-14-39-8-7-31(15)26-21-4-5-22(16-3-6-23(38-2)19(9-16)13-33)28-25(21)29-24(30-26)17-10-18(27(34)35)12-20(11-17)32(36)37/h3-6,9-12,15,33H,7-8,13-14H2,1-2H3,(H,34,35)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8.70	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM50348452 (AZD-8055 | CHEMBL1801204 | US9102670, 1a) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	8.90	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174478 (US9102670, 4l) Show SMILES CNCc1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C25H32N6O2/c1-17-15-32-11-9-30(17)24-21-7-8-22(20-6-4-5-19(13-20)14-26-3)27-23(21)28-25(29-24)31-10-12-33-16-18(31)2/h4-8,13,17-18,26H,9-12,14-16H2,1-3H3/t17-,18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9.10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174333 (US9102670, 1ax) Show SMILES C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(nc2n1)-c1cccc(c1)C(O)=O |r| Show InChI InChI=1S/C24H27N5O4/c1-15-13-32-10-8-28(15)22-19-6-7-20(17-4-3-5-18(12-17)23(30)31)25-21(19)26-24(27-22)29-9-11-33-14-16(29)2/h3-7,12,15-16H,8-11,13-14H2,1-2H3,(H,30,31)/t15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9.20	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174724 (US9102670, 18dn) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@H]1C |r| Show InChI InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9.40	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174695 (US9102670, 18ck) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N(CCO)CCO)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H31N5O5/c1-16-15-34-12-9-29(16)23-19-4-5-20(17-3-6-21(33-2)18(13-17)14-32)25-22(19)26-24(27-23)28(7-10-30)8-11-31/h3-6,13,16,30-32H,7-12,14-15H2,1-2H3/t16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9.5	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM174685 (US9102670, 18bz) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(NCC(F)F)nc2n1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C22H25F2N5O3/c1-13-12-32-8-7-29(13)21-16-4-5-17(14-3-6-18(31-2)15(9-14)11-30)26-20(16)27-22(28-21)25-10-19(23)24/h3-6,9,13,19,30H,7-8,10-12H2,1-2H3,(H,25,26,27,28)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase mTOR (Homo sapiens (Human))	BDBM50429716 (CHEMBL2336332 | US9102670, 18bn) Show SMILES COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CC[C@@H](O)C1)N1CCOC[C@@H]1C |r| Show InChI InChI=1S/C24H29N5O4/c1-15-14-33-10-9-29(15)23-19-4-5-20(16-3-6-21(32-2)17(11-16)13-30)25-22(19)26-24(27-23)28-8-7-18(31)12-28/h3-6,11,15,18,30-31H,7-10,12-14H2,1-2H3/t15-,18+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	25
KUDOS PHARMACEUTICALS LIMITED US Patent					Assay Description The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...				US Patent US9102670 (2015) BindingDB Entry DOI: 10.7270/Q26M35MZ
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 445 total )  |  Next  |  Last  >>

Jump to: